Familial Progressive Supranuclear Palsy: A Literature Review

被引:12
|
作者
Fujioka, Shinsuke [1 ]
Van Gerpen, Jay A. [1 ]
Uitti, Ryan J. [1 ]
Dickson, Dennis W. [2 ]
Wszolek, Zbigniew K. [1 ]
机构
[1] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA
[2] Mayo Clin, Dept Neuropathol, Jacksonville, FL 32224 USA
关键词
Familial progressive supranuclear palsy; MAPT; 2; SIBLINGS; MUTATIONS;
D O I
10.1159/000354975
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Many genes/loci associated with Parkinsonian disorders have been identified. However, the genetic causes for a number of familial forms of Parkinsonian disorders remain to be elucidated. Objective: It was the aim of this paper to review the familial progressive supranuclear palsy (PSP) cases without any known gene mutations published in the English literature. Methods: We searched the PubMed database for reports of familial PSP cases without known mutations. Results: We found 19 PSP families. The mean age at onset was approximately 60 years, and the mean disease duration was about 8 years. Parkinsonism and ophthalmoplegia were most frequently reported, and a vast majority of patients manifested with these two symptoms. Other symptoms such as falls, postural instability and pyramidal signs were also common. A small subset of patients transiently responded to L-dopa therapy. Conclusion: There is an increasing number of reported familial PSP. A recently performed genome-wide association study indicated genetic factors for this condition. Furthermore, clinical, pathological and genetic investigations will open new avenues to the discovery of causative genes and new therapeutics for PSP. (C) 2013 S. Karger AG, Basel
引用
收藏
页码:180 / 182
页数:3
相关论文
共 50 条
  • [21] WEBINO Syndrome in a Patient with Progressive Supranuclear Palsy: Case Report and Literature Review
    Sherstyuk E.E.
    Belyakova-Bodina A.I.
    Nuzhnyi E.P.
    Shpilyukova Y.A.
    Broutian A.G.
    Human Physiology, 2022, 48 (8) : 912 - 918
  • [22] Dysphagia in progressive supranuclear palsy: A scoping review
    Flynn, Eadaoin
    Regan, Julie
    Glinzer, Julia
    O'Dowd, Sean
    Walshe, Margaret
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2024, 11
  • [23] Familial aggregation of related disorders in progressive supranuclear palsy (PSP)
    Kaat, Laura Donker
    Boon, Agnita J.
    Kamphorst, Wouter
    Heutink, Peter
    van Swieten, John C.
    NEUROLOGY, 2008, 70 (11) : A228 - A229
  • [24] A Review of Treatment Options for Progressive Supranuclear Palsy
    Maria Stamelou
    Günter Höglinger
    CNS Drugs, 2016, 30 : 629 - 636
  • [25] Sequence analysis of tau in familial and sporadic progressive supranuclear palsy
    Morris, HR
    Katzenschlager, R
    Janssen, JC
    Brown, JM
    Ozansoy, M
    Quinn, N
    Revesz, T
    Rossor, MN
    Daniel, SE
    Wood, NW
    Lees, AJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (03): : 388 - 390
  • [26] A Review of Treatment Options for Progressive Supranuclear Palsy
    Stamelou, Maria
    Hoeglinger, Gunter
    CNS DRUGS, 2016, 30 (07) : 629 - 636
  • [27] A Retrospective Review of Amantadine in Progressive Supranuclear Palsy
    McFarland, N.
    Farrukh, R.
    Mahn, S.
    MOVEMENT DISORDERS, 2023, 38 : S88 - S88
  • [28] Recent Advances in Progressive Supranuclear Palsy: A Review
    Kaat, L. D.
    Chiu, W. Z.
    Boon, A. J. W.
    van Swieten, J. C.
    CURRENT ALZHEIMER RESEARCH, 2011, 8 (03) : 295 - 302
  • [29] Hidden Gems in the Neurological Literature of Progressive Supranuclear Palsy
    LeWitt, Peter A.
    JOURNAL OF PARKINSONS DISEASE, 2024, 14 (04) : 639 - 642
  • [30] PROGRESSIVE SUPRANUCLEAR PALSY
    Skenderoska, I.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 59 - 59